Related Experiment Video
Updated: Mar 29, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory Markers for the General Cardiology Practitioner: A Primer
Samuel A McFarlane1, Nathaniel P Murphy2, Matthew J Feinstein3
1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Insights
This review explains how to detect and monitor cardiovascular inflammation using blood tests like C-reactive protein (CRP) and imaging techniques such as cardiac MRI. Understanding these markers aids in accurate diagnosis and treatment of heart diseases.
Area of Science:
- Cardiology
- Immunology
- Medical Imaging
Background:
- Cardiovascular diseases (CVDs) share inflammation as a common pathogenic and progressive factor.
- Conditions like atherosclerosis, myocarditis, pericarditis, and heart failure are driven by inflammation.
Purpose of the Study:
- To provide cardiologists with a practical overview of serologic and imaging markers for cardiovascular inflammation.
- To enhance understanding of diagnostic and prognostic tools for cardiac inflammation.
Main Methods:
- Review of common serologic markers: C-reactive protein (CRP), IL-6, and complete blood count (CBC).
- Highlighting imaging modalities: cardiac MRI, CT, and FDG-PET/CT for characterizing myocardial inflammation.
Main Results:
- Serologic markers (CRP, IL-6, CBC) play crucial roles in diagnosis and prognosis.
- Imaging techniques (MRI, CT, PET/CT) effectively characterize myocardial inflammation.
- Integrated use of biomarkers and imaging improves diagnostic accuracy.
Conclusions:
- An integrated approach to cardiovascular inflammation assessment is vital.
- Utilizing both serologic and imaging markers enhances diagnostic accuracy and guides targeted therapy.
- Improved management of various cardiovascular conditions is achievable through comprehensive inflammation monitoring.
Abstract:
Inflammation underlies the pathogenesis and progression of a wide spectrum of cardiovascular diseases including atherosclerosis, myocarditis, pericarditis, and heart failure. This review serves as a primer for the general cardiologist with a practical overview of key serologic and imaging markers used to detect and monitor cardiovascular inflammation. Common serologic markers such as C-reactive protein, interleukin-6, and complete blood count are discussed for their diagnostic and prognostic roles. Imaging modalities including cardiac magnetic resonance imaging, computed tomography, and fluorodeoxyglucose positron emission tomography/computed tomography are highlighted for their ability to characterize myocardial inflammation. An integrated understanding of these biomarkers and imaging approaches can enhance diagnostic accuracy, guide targeted therapy, and support management across a variety of cardiovascular conditions.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies